Shehnaaz Suliman
Direktor/Vorstandsmitglied bei ULTRAGENYX PHARMACEUTICAL INC.
Vermögen: 775 401 $ am 30.04.2024
Aktive Positionen von Shehnaaz Suliman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Direktor/Vorstandsmitglied | 30.01.2019 | - |
| Independent Dir/Board Member | 30.01.2019 | - | |
| 10X GENOMICS, INC. | Direktor/Vorstandsmitglied | 01.08.2019 | - |
| Independent Dir/Board Member | 01.08.2019 | - | |
Executive Women in Bio
 Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Vorsitzender | - | - |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Direktor/Vorstandsmitglied | 11.01.2022 | - |
| Vorstandsvorsitzender | 11.01.2022 | - |
Karriereverlauf von Shehnaaz Suliman
Ehemalige bekannte Positionen von Shehnaaz Suliman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALECTOR, INC. | Vorstandsvorsitzender | 11.12.2019 | 15.12.2021 |
| Geschäftsführer | 11.12.2019 | 01.01.2022 | |
| Präsident | 11.12.2019 | 15.12.2021 | |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Direktor/Vorstandsmitglied | 01.10.2017 | 01.07.2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01.07.2017 | 31.03.2019 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01.06.2015 | 01.07.2017 |
Ausbildung von Shehnaaz Suliman
| Saïd Business School | Masters Business Admin |
| University of Oxford | Graduate Degree |
| University of Cape Town | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 3 |
| Südafrika | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 2 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Health Technology |
Executive Women in Bio
Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Commercial Services |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
- Börse
- Insiders
- Shehnaaz Suliman
- Erfahrung
